Geode Capital Management, LLC Lineage Cell Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,596,006 shares of LCTX stock, worth $3.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,596,006
Previous 3,253,056 10.54%
Holding current value
$3.31 Million
Previous $4.81 Million 25.3%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$0.89 - $1.47 $305,225 - $504,136
342,950 Added 10.54%
3,596,006 $3.6 Million
Q1 2024

May 13, 2024
BUY
$0.86 - $1.48 $272,830 - $469,522
317,245 Added 10.81%
3,253,056 $4.81 Million
Q4 2023

Feb 13, 2024
BUY
$0.91 - $1.35 $153,675 - $227,979
168,874 Added 6.1%
2,935,811 $3.2 Million
Q3 2023

Nov 13, 2023
BUY
$1.16 - $1.53 $401,509 - $529,577
346,129 Added 14.3%
2,766,937 $3.26 Million
Q2 2023

Aug 11, 2023
BUY
$1.26 - $1.53 $1.43 Million - $1.74 Million
1,138,808 Added 88.83%
2,420,808 $3.41 Million
Q1 2023

May 15, 2023
BUY
$1.2 - $1.53 $21,109 - $26,914
17,591 Added 1.39%
1,282,000 $1.92 Million
Q4 2022

Feb 13, 2023
BUY
$1.02 - $1.5 $13,518 - $19,879
13,253 Added 1.06%
1,264,409 $1.48 Million
Q3 2022

Nov 14, 2022
BUY
$1.13 - $1.77 $2,015 - $3,157
1,784 Added 0.14%
1,251,156 $1.41 Million
Q2 2022

Aug 12, 2022
SELL
$1.12 - $1.61 $1.15 Million - $1.65 Million
-1,026,601 Reduced 45.11%
1,249,372 $1.97 Million
Q1 2022

May 13, 2022
SELL
$1.21 - $2.48 $65,555 - $134,361
-54,178 Reduced 2.33%
2,275,973 $3.5 Million
Q4 2021

Feb 11, 2022
SELL
$1.84 - $2.68 $20,907 - $30,452
-11,363 Reduced 0.49%
2,330,151 $5.71 Million
Q3 2021

Nov 12, 2021
BUY
$2.26 - $2.86 $6,621 - $8,379
2,930 Added 0.13%
2,341,514 $5.9 Million
Q2 2021

Aug 13, 2021
BUY
$2.17 - $3.0 $2.33 Million - $3.22 Million
1,072,633 Added 84.73%
2,338,584 $6.66 Million
Q1 2021

May 12, 2021
BUY
$1.77 - $3.1 $355,171 - $622,052
200,662 Added 18.84%
1,265,951 $2.97 Million
Q4 2020

Feb 12, 2021
BUY
$0.95 - $1.83 $41,557 - $80,053
43,745 Added 4.28%
1,065,289 $1.87 Million
Q2 2020

Aug 13, 2020
SELL
$0.71 - $1.18 $465,742 - $774,050
-655,975 Reduced 39.1%
1,021,544 $888,000
Q1 2020

May 14, 2020
BUY
$0.6 - $1.58 $65,275 - $171,891
108,792 Added 6.94%
1,677,519 $1.39 Million
Q4 2019

Feb 13, 2020
BUY
$0.54 - $1.01 $15,087 - $28,218
27,939 Added 1.81%
1,568,727 $1.4 Million
Q3 2019

Nov 12, 2019
BUY
$0.85 - $1.24 $1.31 Million - $1.91 Million
1,540,788 New
1,540,788 $1.51 Million

Others Institutions Holding LCTX

# of Institutions
121
Shares Held
94.3M
Call Options Held
31.3K
Put Options Held
400
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $156M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email